MedPath

Analysis of the effect of intravitreal methotrexate for refractory intraocular inflammatio

Not Applicable
Conditions
Refractory intraocular inflammation
Registration Number
JPRN-UMIN000013595
Lead Sponsor
Institute of Health Biosiences, The University of Tokushima Graduate School
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1)history of serious adverse reaction by methotrexate 2)active infectious disease of eye 3)patient who was judged by doctor not to be able to receive drug

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate improvement of intraocular inflammation after treatment for 6 months
Secondary Outcome Measures
NameTimeMethod
Adverse event
© Copyright 2025. All Rights Reserved by MedPath